Improvement of gait and balance by non-invasive brain stimulation: its use in rehabilitation

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Introduction: Gait and balance impairments are common in many neurological disorders and among the elderly, are often difficult to treat, and have a significant effect on quality of life. Areas covered: Non-invasive brain stimulation (NIBS) technologies have been recognized for their therapeutic potential in various neurologic and psychiatric disorders. There is increasing interest in treatment of gait and balance impairment using newer modalities such as NIBS. Most therapeutic trials so far have been of small size and heterogeneous in design and stimulus parameters. Several controlled trials have begun to provide evidence for short-term improvement of gait and balance in some neurological disorders such as stroke and Parkinson's Disease. Trials in other neurological disorders are few and none in aged related impairment of gait and balance. Expert commentary: Large, well-designed clinical trials are needed to corroborate the early positive findings and confirm its durability and the overall clinical relevance.

Original languageEnglish
Pages (from-to)133-144
Number of pages12
JournalExpert Review of Neurotherapeutics
Volume19
Issue number2
DOIs
Publication statusPublished - 1 Feb 2019

Cite this

@article{674d507254c045eb94053ae00cb4d3c2,
title = "Improvement of gait and balance by non-invasive brain stimulation: its use in rehabilitation",
abstract = "Introduction: Gait and balance impairments are common in many neurological disorders and among the elderly, are often difficult to treat, and have a significant effect on quality of life. Areas covered: Non-invasive brain stimulation (NIBS) technologies have been recognized for their therapeutic potential in various neurologic and psychiatric disorders. There is increasing interest in treatment of gait and balance impairment using newer modalities such as NIBS. Most therapeutic trials so far have been of small size and heterogeneous in design and stimulus parameters. Several controlled trials have begun to provide evidence for short-term improvement of gait and balance in some neurological disorders such as stroke and Parkinson's Disease. Trials in other neurological disorders are few and none in aged related impairment of gait and balance. Expert commentary: Large, well-designed clinical trials are needed to corroborate the early positive findings and confirm its durability and the overall clinical relevance.",
keywords = "Non-invasive brain stimulation, transcranial magnetic stimulation, transcranial direct current stimulation, neurorehabilitation, gait, balance, TRANSCRANIAL MAGNETIC STIMULATION, HUMAN MOTOR CORTEX, DORSOLATERAL PREFRONTAL CORTEX, THETA-BURST STIMULATION, PARKINSONS-DISEASE, FUNCTIONAL MOBILITY, SPASTICITY MANAGEMENT, LOCOMOTOR ADAPTATION, STROKE, EXCITABILITY",
author = "Soumya Ghosh",
year = "2019",
month = "2",
day = "1",
doi = "10.1080/14737175.2019.1564042",
language = "English",
volume = "19",
pages = "133--144",
journal = "Expert Review of Neurotherapeutics",
issn = "1473-7175",
publisher = "Taylor & Francis",
number = "2",

}

Improvement of gait and balance by non-invasive brain stimulation : its use in rehabilitation. / Ghosh, Soumya.

In: Expert Review of Neurotherapeutics, Vol. 19, No. 2, 01.02.2019, p. 133-144.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Improvement of gait and balance by non-invasive brain stimulation

T2 - its use in rehabilitation

AU - Ghosh, Soumya

PY - 2019/2/1

Y1 - 2019/2/1

N2 - Introduction: Gait and balance impairments are common in many neurological disorders and among the elderly, are often difficult to treat, and have a significant effect on quality of life. Areas covered: Non-invasive brain stimulation (NIBS) technologies have been recognized for their therapeutic potential in various neurologic and psychiatric disorders. There is increasing interest in treatment of gait and balance impairment using newer modalities such as NIBS. Most therapeutic trials so far have been of small size and heterogeneous in design and stimulus parameters. Several controlled trials have begun to provide evidence for short-term improvement of gait and balance in some neurological disorders such as stroke and Parkinson's Disease. Trials in other neurological disorders are few and none in aged related impairment of gait and balance. Expert commentary: Large, well-designed clinical trials are needed to corroborate the early positive findings and confirm its durability and the overall clinical relevance.

AB - Introduction: Gait and balance impairments are common in many neurological disorders and among the elderly, are often difficult to treat, and have a significant effect on quality of life. Areas covered: Non-invasive brain stimulation (NIBS) technologies have been recognized for their therapeutic potential in various neurologic and psychiatric disorders. There is increasing interest in treatment of gait and balance impairment using newer modalities such as NIBS. Most therapeutic trials so far have been of small size and heterogeneous in design and stimulus parameters. Several controlled trials have begun to provide evidence for short-term improvement of gait and balance in some neurological disorders such as stroke and Parkinson's Disease. Trials in other neurological disorders are few and none in aged related impairment of gait and balance. Expert commentary: Large, well-designed clinical trials are needed to corroborate the early positive findings and confirm its durability and the overall clinical relevance.

KW - Non-invasive brain stimulation

KW - transcranial magnetic stimulation

KW - transcranial direct current stimulation

KW - neurorehabilitation

KW - gait

KW - balance

KW - TRANSCRANIAL MAGNETIC STIMULATION

KW - HUMAN MOTOR CORTEX

KW - DORSOLATERAL PREFRONTAL CORTEX

KW - THETA-BURST STIMULATION

KW - PARKINSONS-DISEASE

KW - FUNCTIONAL MOBILITY

KW - SPASTICITY MANAGEMENT

KW - LOCOMOTOR ADAPTATION

KW - STROKE

KW - EXCITABILITY

U2 - 10.1080/14737175.2019.1564042

DO - 10.1080/14737175.2019.1564042

M3 - Review article

VL - 19

SP - 133

EP - 144

JO - Expert Review of Neurotherapeutics

JF - Expert Review of Neurotherapeutics

SN - 1473-7175

IS - 2

ER -